Product Information
SPINOSAD 0.9% TOPICAL SUSP is a generic product labeled by Allegis Pharmaceuticals, LLC, priced at $2.0169 per ML under NDC 28595057004. Its NADAC has been published 266 times since Sep 10, 2014.
FDA first approved this application on Jan 18, 2011.
Strength
9 mg/mL
Manufacturer
Allegis Pharmaceuticals, LLCNDC
28595057004
Classification
Generic
Dosage Form
SUSPENSION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SPINOSADApproval Type
Authorized Generic (NDA)
FDA Application
NDA022408FDA Approved
1/18/2011
On Market Since
6/25/2014
Pharmacological Classes
Price Statistics
The NADAC for SPINOSAD 0.9% TOPICAL SUSP has been published 266 times since Sep 10, 2014, and over the history we have for it it has risen 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0169 per ML |
|---|---|
| All-time high | $2.0261 (Aug 12, 2026) |
| All-time low | $1.5237 (Sep 10, 2014) |
| 52-week high | $2.0261 |
| 52-week low | $1.8812 |
| Median price | $1.6430 |
| Average price | $1.6959 |
| Largest weekly change | -12.4% (Jan 18, 2017) |
| Weeks tracked | 266 |
| Tracking since | Sep 10, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allegis Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
spinosad market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Pediculicide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SPINOSAD 0.9% TOPICAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SPINOSAD 0.9% TOPICAL SUSP, manufactured by Allegis Pharmaceuticals, LLC, is $2.0169 per ML (NDC 28595057004), effective Sep 30, 2026.
How has the price of SPINOSAD 0.9% TOPICAL SUSP changed over time?
Over the history we have for it, the NADAC for SPINOSAD 0.9% TOPICAL SUSP has risen 32.4%. It has been tracked across 266 weekly CMS publications since Sep 10, 2014.
What are the highest and lowest recorded NADAC prices for SPINOSAD 0.9% TOPICAL SUSP?
Since Sep 10, 2014, the NADAC for SPINOSAD 0.9% TOPICAL SUSP has ranged from a low of $1.5237 (Sep 10, 2014) to a high of $2.0261 (Aug 12, 2026), with a median of $1.6430 per ML.
Are there cheaper alternatives to SPINOSAD 0.9% TOPICAL SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SPINOSAD 0.9% TOPICAL SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures SPINOSAD 0.9% TOPICAL SUSP?
SPINOSAD 0.9% TOPICAL SUSP (NDC 28595057004) is labeled by Allegis Pharmaceuticals, LLC, and CMS classifies it as a generic product.